Loading...

APC anti-mouse CD4 Antibody APC anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_APC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
  • GK1.5_APC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100412 100 µg NOK1089
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100411 25 µg NOK322
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Fang A, et al. 2022. J Virol. 96:e0105022. PubMed
  2. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  3. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  4. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  5. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  6. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  7. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  8. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  9. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  10. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  11. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  12. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  13. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  14. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  15. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  16. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  17. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  18. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  19. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  20. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  21. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  22. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  23. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  24. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  25. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  26. Wang L, et al. 2022. ACS Pharmacol Transl Sci. 5:110. PubMed
  27. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  28. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  29. Campisi L, et al. 2022. Nature. 606:945. PubMed
  30. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  31. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  32. Shi Z, et al. 2022. Br J Pharmacol. 179:5209. PubMed
  33. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  34. TaSli PN, et al. 2022. J Food Biochem. 46:e14393. PubMed
  35. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  36. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  37. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  38. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  39. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  40. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  41. Edwards CL, et al. 2023. J Clin Invest. 133: . PubMed
  42. Cousin N, et al. 2022. Cells. 12: . PubMed
  43. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  44. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  45. Lee JY, et al. 2023. Cancer Immunol Immunother. :. PubMed
  46. Patton T, et al. 2023. Cell Death Dis. 14:111. PubMed
  47. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  48. Han S, et al. 2022. Cancer Immunol Res. 10:437. PubMed
  49. Berube A, et al. 2022. Viruses. 14:. PubMed
  50. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  51. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  52. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  53. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  54. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  55. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  56. Geng Z, et al. 2021. Nat Commun. 12:6584. PubMed
  57. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  58. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  59. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  60. Schmidt V, et al. 2021. J Cell Biol. 220:. PubMed
  61. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  62. Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed
  63. Oh DS, et al. 2021. Autophagy. 17:2111. PubMed
  64. Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed
  65. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  66. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  67. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  68. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  69. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  70. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  71. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  72. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  73. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  74. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  75. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  76. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  77. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  78. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  79. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  80. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  81. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  82. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  83. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  84. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  85. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  86. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  87. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  88. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  89. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  90. Wei SC, et al. 2020. Cancer Discov. . PubMed
  91. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  92. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  93. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  94. Khatun A, et al. 2021. J Exp Med. 218:. PubMed
  95. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  96. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  97. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  98. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  99. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  100. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  101. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  102. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  103. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  104. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  105. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  106. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  107. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  108. Li J, et al. 2020. Elife. 9:00. PubMed
  109. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  110. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  111. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  112. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  113. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  114. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  115. Yang J, et al. 2020. Nature. 586:572. PubMed
  116. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  117. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  118. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  119. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  120. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  121. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  122. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  123. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  124. Takano T, et al. 2020. Front Immunol. 11:1555. PubMed
  125. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  126. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  127. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  128. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  129. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  130. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  131. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  132. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  133. Tan YY, et al. 2021. Exp Ther Med. 22:1368. PubMed
  134. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  135. Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
  136. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  137. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  138. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  139. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  140. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  141. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  142. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  143. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  144. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  145. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  146. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  147. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  148. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  149. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  150. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  151. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  152. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  153. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  154. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  155. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  156. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  157. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  158. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  159. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  160. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  161. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  162. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  163. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  164. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  165. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  166. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  167. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  168. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  169. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  170. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  171. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  172. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  173. Kanatsu-Shinohara M, et al. 2022. J Reprod Dev. Online ahead of print. PubMed
  174. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  175. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  176. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  177. Lo W, et al. 2014. Elife. 14:1457. PubMed
  178. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  179. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  180. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  181. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  182. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  183. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  184. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  185. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  186. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  187. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  188. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  189. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  190. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  191. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  192. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  193. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  194. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  195. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  196. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  197. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  198. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  199. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  200. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  201. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  202. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  203. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  204. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  205. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  206. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  207. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  208. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  209. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  210. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  211. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  212. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  213. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  214. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  215. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  216. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  217. Yang H, et al. 2022. Viruses. 14:. PubMed
  218. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  219. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  220. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  221. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
  222. Fang A, et al. 2022. J Virol. 96:e0105022. PubMed
  223. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  224. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  225. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  226. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  227. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  228. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  229. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  230. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  231. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  232. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  233. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  234. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  235. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  236. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  237. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  238. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  239. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  240. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  241. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  242. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  243. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  244. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  245. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  246. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  247. Wang L, et al. 2022. ACS Pharmacol Transl Sci. 5:110. PubMed
  248. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  249. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  250. Campisi L, et al. 2022. Nature. 606:945. PubMed
  251. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  252. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  253. Shi Z, et al. 2022. Br J Pharmacol. 179:5209. PubMed
  254. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  255. TaSli PN, et al. 2022. J Food Biochem. 46:e14393. PubMed
  256. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  257. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  258. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  259. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  260. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  261. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  262. Edwards CL, et al. 2023. J Clin Invest. 133: . PubMed
  263. Cousin N, et al. 2022. Cells. 12: . PubMed
  264. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  265. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  266. Lee JY, et al. 2023. Cancer Immunol Immunother. :. PubMed
  267. Patton T, et al. 2023. Cell Death Dis. 14:111. PubMed
  268. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  269. Han S, et al. 2022. Cancer Immunol Res. 10:437. PubMed
  270. Berube A, et al. 2022. Viruses. 14:. PubMed
  271. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  272. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  273. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  274. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  275. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  276. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  277. Geng Z, et al. 2021. Nat Commun. 12:6584. PubMed
  278. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  279. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  280. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  281. Schmidt V, et al. 2021. J Cell Biol. 220:. PubMed
  282. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  283. Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed
  284. Oh DS, et al. 2021. Autophagy. 17:2111. PubMed
  285. Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed
  286. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  287. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  288. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  289. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  290. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  291. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  292. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  293. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  294. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  295. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  296. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  297. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  298. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  299. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  300. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  301. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  302. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  303. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  304. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  305. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  306. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  307. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  308. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  309. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  310. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  311. Wei SC, et al. 2020. Cancer Discov. . PubMed
  312. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  313. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  314. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  315. Khatun A, et al. 2021. J Exp Med. 218:. PubMed
  316. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  317. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  318. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  319. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  320. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  321. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  322. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  323. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  324. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  325. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  326. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  327. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  328. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  329. Li J, et al. 2020. Elife. 9:00. PubMed
  330. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  331. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  332. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  333. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  334. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  335. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  336. Yang J, et al. 2020. Nature. 586:572. PubMed
  337. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  338. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  339. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  340. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  341. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  342. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  343. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  344. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  345. Takano T, et al. 2020. Front Immunol. 11:1555. PubMed
  346. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  347. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  348. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  349. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  350. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  351. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  352. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  353. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  354. Tan YY, et al. 2021. Exp Ther Med. 22:1368. PubMed
  355. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  356. Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
  357. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  358. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  359. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  360. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  361. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  362. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  363. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  364. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  365. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  366. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  367. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  368. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  369. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  370. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  371. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  372. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  373. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  374. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  375. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  376. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  377. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  378. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  379. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  380. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  381. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  382. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  383. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  384. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  385. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  386. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  387. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  388. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  389. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  390. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  391. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  392. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  393. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  394. Kanatsu-Shinohara M, et al. 2022. J Reprod Dev. Online ahead of print. PubMed
  395. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  396. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  397. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  398. Lo W, et al. 2014. Elife. 14:1457. PubMed
  399. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  400. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  401. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  402. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  403. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  404. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  405. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  406. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  407. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  408. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  409. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  410. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  411. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  412. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  413. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  414. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  415. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  416. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  417. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  418. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  419. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  420. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  421. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  422. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  423. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  424. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  425. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  426. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  427. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  428. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  429. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  430. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  431. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  432. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  433. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  434. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  435. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  436. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  437. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  438. Yang H, et al. 2022. Viruses. 14:. PubMed
  439. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  440. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  441. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  442. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
RRID
AB_312697 (BioLegend Cat. No. 100412)
AB_312696 (BioLegend Cat. No. 100411)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC

Customers Also Purchased

FITC anti-mouse CD3
Clone: 17A2

FITC anti-mouse CD4
Clone: GK1.5

PE anti-mouse CD8a
Clone: 53-6.7

PE anti-mouse CD4
Clone: GK1.5

Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_APC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
  • GK1.5_APC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100412 100 µg NOK1089
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100411 25 µg NOK322
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Fang A, et al. 2022. J Virol. 96:e0105022. PubMed
  2. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  3. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  4. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  5. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  6. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  7. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  8. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  9. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  10. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  11. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  12. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  13. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  14. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  15. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  16. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  17. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  18. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  19. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  20. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  21. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  22. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  23. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  24. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  25. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  26. Wang L, et al. 2022. ACS Pharmacol Transl Sci. 5:110. PubMed
  27. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  28. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  29. Campisi L, et al. 2022. Nature. 606:945. PubMed
  30. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  31. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  32. Shi Z, et al. 2022. Br J Pharmacol. 179:5209. PubMed
  33. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  34. TaSli PN, et al. 2022. J Food Biochem. 46:e14393. PubMed
  35. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  36. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  37. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  38. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  39. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  40. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  41. Edwards CL, et al. 2023. J Clin Invest. 133: . PubMed
  42. Cousin N, et al. 2022. Cells. 12: . PubMed
  43. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  44. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  45. Lee JY, et al. 2023. Cancer Immunol Immunother. :. PubMed
  46. Patton T, et al. 2023. Cell Death Dis. 14:111. PubMed
  47. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  48. Han S, et al. 2022. Cancer Immunol Res. 10:437. PubMed
  49. Berube A, et al. 2022. Viruses. 14:. PubMed
  50. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  51. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  52. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  53. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  54. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  55. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  56. Geng Z, et al. 2021. Nat Commun. 12:6584. PubMed
  57. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  58. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  59. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  60. Schmidt V, et al. 2021. J Cell Biol. 220:. PubMed
  61. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  62. Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed
  63. Oh DS, et al. 2021. Autophagy. 17:2111. PubMed
  64. Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed
  65. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  66. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  67. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  68. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  69. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  70. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  71. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  72. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  73. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  74. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  75. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  76. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  77. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  78. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  79. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  80. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  81. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  82. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  83. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  84. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  85. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  86. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  87. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  88. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  89. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  90. Wei SC, et al. 2020. Cancer Discov. . PubMed
  91. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  92. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  93. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  94. Khatun A, et al. 2021. J Exp Med. 218:. PubMed
  95. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  96. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  97. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  98. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  99. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  100. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  101. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  102. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  103. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  104. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  105. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  106. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  107. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  108. Li J, et al. 2020. Elife. 9:00. PubMed
  109. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  110. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  111. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  112. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  113. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  114. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  115. Yang J, et al. 2020. Nature. 586:572. PubMed
  116. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  117. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  118. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  119. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  120. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  121. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  122. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  123. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  124. Takano T, et al. 2020. Front Immunol. 11:1555. PubMed
  125. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  126. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  127. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  128. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  129. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  130. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  131. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  132. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  133. Tan YY, et al. 2021. Exp Ther Med. 22:1368. PubMed
  134. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  135. Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
  136. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  137. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  138. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  139. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  140. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  141. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  142. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  143. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  144. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  145. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  146. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  147. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  148. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  149. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  150. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  151. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  152. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  153. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  154. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  155. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  156. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  157. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  158. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  159. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  160. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  161. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  162. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  163. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  164. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  165. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  166. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  167. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  168. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  169. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  170. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  171. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  172. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  173. Kanatsu-Shinohara M, et al. 2022. J Reprod Dev. Online ahead of print. PubMed
  174. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  175. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  176. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  177. Lo W, et al. 2014. Elife. 14:1457. PubMed
  178. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  179. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  180. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  181. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  182. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  183. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  184. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  185. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  186. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  187. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  188. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  189. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  190. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  191. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  192. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  193. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  194. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  195. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  196. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  197. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  198. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  199. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  200. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  201. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  202. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  203. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  204. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  205. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  206. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  207. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  208. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  209. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  210. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  211. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  212. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  213. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  214. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  215. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  216. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  217. Yang H, et al. 2022. Viruses. 14:. PubMed
  218. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  219. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  220. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  221. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
  222. Fang A, et al. 2022. J Virol. 96:e0105022. PubMed
  223. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  224. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  225. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  226. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  227. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  228. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  229. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  230. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  231. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  232. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  233. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  234. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  235. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  236. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  237. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  238. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  239. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  240. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  241. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  242. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  243. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  244. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  245. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  246. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  247. Wang L, et al. 2022. ACS Pharmacol Transl Sci. 5:110. PubMed
  248. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  249. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  250. Campisi L, et al. 2022. Nature. 606:945. PubMed
  251. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  252. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  253. Shi Z, et al. 2022. Br J Pharmacol. 179:5209. PubMed
  254. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  255. TaSli PN, et al. 2022. J Food Biochem. 46:e14393. PubMed
  256. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  257. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  258. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  259. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  260. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  261. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  262. Edwards CL, et al. 2023. J Clin Invest. 133: . PubMed
  263. Cousin N, et al. 2022. Cells. 12: . PubMed
  264. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  265. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  266. Lee JY, et al. 2023. Cancer Immunol Immunother. :. PubMed
  267. Patton T, et al. 2023. Cell Death Dis. 14:111. PubMed
  268. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  269. Han S, et al. 2022. Cancer Immunol Res. 10:437. PubMed
  270. Berube A, et al. 2022. Viruses. 14:. PubMed
  271. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  272. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  273. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  274. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  275. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  276. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  277. Geng Z, et al. 2021. Nat Commun. 12:6584. PubMed
  278. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  279. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  280. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  281. Schmidt V, et al. 2021. J Cell Biol. 220:. PubMed
  282. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  283. Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed
  284. Oh DS, et al. 2021. Autophagy. 17:2111. PubMed
  285. Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed
  286. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  287. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  288. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  289. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  290. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  291. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  292. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  293. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  294. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  295. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  296. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  297. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  298. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  299. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  300. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  301. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  302. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  303. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  304. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  305. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  306. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  307. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  308. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  309. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  310. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  311. Wei SC, et al. 2020. Cancer Discov. . PubMed
  312. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  313. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  314. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  315. Khatun A, et al. 2021. J Exp Med. 218:. PubMed
  316. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  317. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  318. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  319. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  320. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  321. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  322. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  323. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  324. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  325. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  326. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  327. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  328. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  329. Li J, et al. 2020. Elife. 9:00. PubMed
  330. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  331. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  332. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  333. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  334. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  335. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  336. Yang J, et al. 2020. Nature. 586:572. PubMed
  337. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  338. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  339. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  340. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  341. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  342. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  343. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  344. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  345. Takano T, et al. 2020. Front Immunol. 11:1555. PubMed
  346. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  347. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  348. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  349. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  350. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  351. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  352. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  353. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  354. Tan YY, et al. 2021. Exp Ther Med. 22:1368. PubMed
  355. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  356. Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
  357. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  358. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  359. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  360. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  361. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  362. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  363. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  364. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  365. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  366. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  367. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  368. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  369. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  370. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  371. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  372. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  373. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  374. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  375. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  376. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  377. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  378. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  379. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  380. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  381. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  382. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  383. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  384. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  385. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  386. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  387. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  388. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  389. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  390. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  391. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  392. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  393. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  394. Kanatsu-Shinohara M, et al. 2022. J Reprod Dev. Online ahead of print. PubMed
  395. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  396. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  397. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  398. Lo W, et al. 2014. Elife. 14:1457. PubMed
  399. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  400. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  401. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  402. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  403. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  404. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  405. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  406. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  407. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  408. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  409. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  410. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  411. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  412. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  413. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  414. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  415. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  416. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  417. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  418. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  419. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  420. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  421. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  422. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  423. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  424. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  425. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  426. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  427. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  428. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  429. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  430. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  431. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  432. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  433. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  434. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  435. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  436. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  437. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  438. Yang H, et al. 2022. Viruses. 14:. PubMed
  439. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  440. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  441. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  442. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
RRID
AB_312697 (BioLegend Cat. No. 100412)
AB_312696 (BioLegend Cat. No. 100411)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC

Customers Also Purchased

FITC anti-mouse CD3
Clone: 17A2

FITC anti-mouse CD4
Clone: GK1.5

PE anti-mouse CD8a
Clone: 53-6.7

PE anti-mouse CD4
Clone: GK1.5

Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account